Description
BLOOD BANK SUPPLIES FOR FY14
First action · last action
2013-10-25 · 2015-01-05
Transactions
3
First transaction's obligation
$168,000
Base + all options value (sum of deltas)
$111,408
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-10-25+$168,000= $168,000
- Mod P000012014-02-25+$0= $168,000
- Mod P000022015-01-05-$56,592= $111,408
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-10-25 | +$168,000 | $168,000 | BLOOD BANK SUPPLIES FOR FY14 |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2014-02-25 | +$0 | $168,000 | BLOOD BANK SUPPLIES FOR FY14 |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2015-01-05 | −$56,592 | $111,408 | BLOOD BANK SUPPLIES FOR FY14 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GE17LEU396S3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426N0493 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS | $253,134 | FY2026 |
| 36C24426D0048 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C24425N0378 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $124,141 | FY2025 |
| 36C24424N0449 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $163,336 | FY2024 |
| 36C24424D0042 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C24423N0440 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $162,313 | FY2023 |
Other recipients under 6550 from 595-LEBANON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24414J2516 | ROCHE DIAGNOSTICS CORPORATION | 595-LEBANON | $23,000 | FY2014 |
| VA24414J2508 | ROCHE DIAGNOSTICS CORPORATION | 595-LEBANON | $7,776 | FY2014 |
| VA24414J0036 | CEPHEID | 595-LEBANON | $175,154 | FY2014 |
| V595A20003 | ORTHO-CLINICAL DIAGNOSTICS, INC | 595-LEBANON | $62,836 | FY2011 |
| V595R18202 | ROCHE DIAGNOSTICS CORPORATION | 595-LEBANON | $4,600 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24414C0026_3600_-NONE-_-NONE- · retrieved 2026-09-26.